Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
February 17, 2023
From Benzinga
Vir Biotech To Work On Next-Gen COVID-19 Solutions Independently, Or With Other Partners, As GSK Walks Out
February 14, 2023
From Benzinga
Eiger BioPharma's Single Dose Of Peginterferon Lambda Cuts Risk Of COVID-19-Related Hospitalizations, Deaths
February 09, 2023
Tickers
EIGR
From Benzinga
Merck's Oral COVID-19 Treatment Might Be Linked To Spreading Mutations, Study Shows
February 03, 2023
Tickers
MRK
From Benzinga
Tonix Pharmaceuticals Seeks To Bolster Its COVID-19 Pipeline With This New Acquisition
February 02, 2023
Tickers
TNXP
From Benzinga
Why Are Biophytis Shares Trading Higher In Premarket Today
February 02, 2023
Tickers
BPTS
From Benzinga
From Benzinga
CureVac Shares Pop After Encouraging Update From COVID-19, Flu mRNA Vaccine Programs
January 30, 2023
From Benzinga
BiondVax Touts Additional Preclinical Data From Inhaled COVID-19 Treatment Candidate
January 23, 2023
Tickers
BVXV
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Receives Additional $8.2M In Closeout Of COVID-19 DoD Contract
January 18, 2023
Tickers
SABS
From Benzinga
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People
January 16, 2023
From Benzinga
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
January 13, 2023
From Benzinga
From Benzinga
From Benzinga
Pfizer Rebuts Generic Version Of COVID-19 Oral Treatment In China, Says It's Not A Poor Country
January 10, 2023
From Benzinga
Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly
January 09, 2023
From Benzinga
China In Talks To Secure License For Generic Version Of Pfizer's COVID-19 Oral Drug
January 09, 2023
From Benzinga
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
January 03, 2023
From Benzinga
Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates
December 30, 2022
Tickers
NVAX
From Benzinga
New Oral COVID-19 Antiviral Might Be Better Than Pfizer's Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows
December 30, 2022
From Benzinga
Merck COVID Antiviral Does Not Reduce Risk Of Hospitalization, Death Rates In Vaccinated Individuals
December 23, 2022
Tickers
MRK
From Benzinga
Oragenics Highlights Encouraging Toxicology Data From Intranasal COVID Vaccine Candidate
December 22, 2022
Tickers
OGEN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.